Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-24 @ 7:40 PM
NCT ID:
NCT06396403
Eligibility Criteria:
Inclusion Criteria:
* Minimum age of 18 years
* HbSC or HbSS genotype
* Recent ophthalmologic examination (up to 2 years prior) or (willingness to attend) upcoming examination
Exclusion Criteria:
* Age below 18 years
* Genotype other than HbSC or HbSS
* No recent ophthalmologic examination and no intention to visit the outpatient clinic for ophthalmic and hematologic examination
* Participation in trials with either crizanlizumab, voxelotor or mitapivat.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06396403
Study Brief:
Protocol Section:
NCT06396403